What is Hello Heart?
Hello Heart operates at the intersection of artificial intelligence and preventative medicine, providing a specialized platform designed to manage heart disease, the leading cause of mortality among U.S. adults. The company's solution integrates connected devices with a mobile application that leverages behavioral science and personalized digital coaching to drive sustainable lifestyle modifications. By empowering users to monitor blood pressure and identify critical health risks in real-time, Hello Heart facilitates proactive medical intervention.
The platform is engineered for seamless integration into employer-sponsored health programs, positioning it as a high-value asset for organizations seeking to reduce healthcare costs while improving employee wellness. Its status as a member of the American Heart Association's Innovators Network and its inclusion in the CVS Health Point Solutions Management program highlight its clinical credibility and operational scalability within the competitive digital health landscape.
How much funding has Hello Heart raised?
Hello Heart has raised a total of $136M across 4 funding rounds:
Series A
$9M
Series B
$12M
Series C
$45M
Series D
$70M
Series A (2018): $9M with participation from BlueRun Ventures, Resolute Ventures, and Maven Ventures
Series B (2019): $12M led by Blue Run Ventures and Khosla Ventures
Series C (2021): $45M supported by BlueRun Ventures, IVP, Khosla Ventures, Resolute.Vc, and Maven Ventures
Series D (2022): $70M featuring Stripes
Key Investors in Hello Heart
Khosla Ventures
A prominent venture capital firm founded by Vinod Khosla that provides strategic advice and capital to breakthrough technology companies across health, AI, and enterprise sectors.
BlueRun Ventures
A global venture capital fund established in 1998 that focuses on early-to-growth stage investments, maintaining a strong international presence across key technology hubs.
IVP
A premier later-stage venture capital firm that specializes in scaling high-growth technology companies through significant minority stakes and strategic support toward IPO or M&A exits.
What's next for Hello Heart?
With the successful closure of its latest financing round, Hello Heart is well-positioned to expand its footprint within the enterprise health market. The company's strategic roadmap likely involves deepening its AI-driven diagnostic capabilities and broadening its reach through existing partnerships with major health benefit providers. As the demand for remote patient monitoring and digital-first chronic disease management continues to surge, Hello Heart is poised to leverage its substantial capital reserves to enhance its product suite and solidify its market leadership.
Future growth will likely focus on increasing user engagement through advanced personalization and expanding the clinical validation of its platform to further integrate with primary care workflows. By maintaining its focus on high-impact cardiovascular health, the company remains a key player in the shift toward value-based care models.
